Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 73124 CHICAGO, IL
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,048,804
+$2,312,694 QoQ
Shares Held
652,849
+266.3% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 89 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. XFOR ranks #203 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in XFOR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,048,804 652,849
2026-03-31 $736,110 178,235
2025-12-31 $712,940 178,235
2025-03-31 $295,899 1,253,815
2024-12-31 $996,432 1,357,539
2024-09-30 $882,810 1,319,599
2024-06-30 $612,482 1,056,006
2024-03-31 $1,465,737 1,054,488
2023-12-31 $891,843 1,062,985
2023-09-30 $1,163,784 1,067,693
2023-06-30 $2,040,693 1,051,904
2023-03-31 $195,288 224,470
2022-12-31 $145,685 146,713
2022-09-30 $145,669 85,187
2022-06-30 $53,823 55,776
2022-03-31 $96,994 55,426
2021-12-31 $154,583 67,504
2021-09-30 $358,973 67,859
2021-06-30 $445,658 68,563
2021-03-31 $1,553,088 180,382
2020-12-31 $1,337,330 207,983
2020-09-30 $1,564,105 231,035
2020-06-30 $2,245,606 240,945
2020-03-31 $1,835,737 183,574